The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I, first-in-human clinical trial of the GDF-15 neutralizing antibody CTL-002 in subjects with advanced-stage solid tumors (ACRONYM: GDFATHER).
 
Ignacio Melero
Honoraria - Bioncotech; PharmaMar
Consulting or Advisory Role - AstraZeneca/MedImmune; Bayer; Bayer; Boston Pharmaceuticals; Bristol-Myers Squibb; crispr therapeutics; EMD Serono; F-star; Genmab; Lilly; MSD; Noxxon Pharma; Numab; Pieris Pharmaceuticals; Roche/Genentech; SERVIER; Tusk Therapeutics; Tusk Therapeutics
Research Funding - Alligator Bioscience; AstraZeneca; Bioncotech; Bristol-Myers Squibb; Roche/Genentech
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Incyte; MSD; Roche/Genentech
 
Emiliano Calvo
Employment - HM Hospitales; START
Leadership - START
Stock and Other Ownership Interests - Oncoart Associated; START
Honoraria - HM Hospitales
Consulting or Advisory Role - Adcendo; Alkermes; Amcure; Amunix; Anaveon; Bristol-Myers Squibb; Janssen-Cilag; Nanobiotix; PharmaMar; PsiOxus Therapeutics; Roche/Genentech; Seagen; Servier; TargImmune Therapeutics
Research Funding - Achilles Therapeutics (Inst); BeiGene; START
Other Relationship - Investigational Therapeutics in Oncological Sciences
 
Reinhard Dummer
Honoraria - Alligator Bioscience; Amgen; Bristol-Myers Squibb; Catalym; MaxiVax; MSD; Novartis; Pierre Fabre; Regeneron; Roche; Sanofi; Second Genome; Sun Pharma; Takeda; touchIME
Consulting or Advisory Role - Alligator Bioscience; Amgen; Bristol-Myers Squibb; Catalym; MaxiVax; MSD; Novartis; Pierre Fabre; Regeneron; Roche; Sanofi; Second Genome; Sun Pharma; Takeda; touchIME
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); MSD (Inst); Novartis (Inst); Roche (Inst)
 
Elena Garralda
Consulting or Advisory Role - Alkermes; Anaveon; Boehringer Ingelheim; Bristol-Myers Squibb; Ellipses Pharma; Janssen; MAB Discovery; NeoMed; Roche; Seagen; TFS; Thermo Fisher Scientific
Speakers' Bureau - Lilly; MSD; Roche; Thermo Fisher Scientific
Research Funding - AstraZeneca/MedImmune; Novartis; Roche (Inst); Taiho Oncology (Inst); Thermo Fisher Scientific (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Glycotope GmbH; Menarini; Merck Sharp & Dohme
 
Martin H. Schuler
Honoraria - Amgen; Boehringer Ingelheim; Bristol-Myers Squibb; Janssen-Cilag; Novartis; Roche Pharma AG
Consulting or Advisory Role - Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; GlaxoSmithKline; MorphoSys; Novartis; Roche; Takeda
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Novartis (Inst)
Patents, Royalties, Other Intellectual Property - Highly sensitive method for mutation detection by PCR (Inst)
 
Maria-Elisabeth Goebeler
Consulting or Advisory Role - Bristol-Myers Squibb; GEMoaB; Janssen-Cilag; Novartis; Roche
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; GEMoaB; Janssen-Cilag; Novartis; Roche
 
Ralf C. Bargou
Honoraria - Amgen; Catalym; GEMoaB
Consulting or Advisory Role - Amgen; Catalym; GEMoaB
Patents, Royalties, Other Intellectual Property - Amgen
 
Tanja Gromke
No Relationships to Disclose
 
Josep Tabernero
Consulting or Advisory Role - Array BioPharma; AstraZeneca; Avvinity; Bayer; Boehringer Ingelheim; Chugai Pharma; Daiichi Sankyo; F. Hoffmann LaRoche; Genentech; HalioDx; Hutchison MediPharma; Ikena Oncology; IQvia; Lilly; Menarini; Merck Serono; Merus; Mirati Therapeutics; MSD; Neophore; Novartis; Orion Biotechnology; Peptomyc; Pfizer; Pierre Fabre; Samsung Bioepis; Sanofi; Seagen; Servier; Taiho Pharmaceutical; Tessa Therapeutics; TheraMyc
Other Relationship - Imedex; Medscape; MJH Life Sciences; Peerview; Physicans' Education Resource
 
Egle Ramelyte
Consulting or Advisory Role - Amgen; Sanofi/Regeneron
Research Funding - Amgen (Inst)
Patents, Royalties, Other Intellectual Property - Contribution to UpToDate chapter update for Superficial acitic porokeratosis.
Travel, Accommodations, Expenses - Amgen; Sanofi
 
Maria De Miguel
Honoraria - Janssen; MSD Oncology; Roche
(OPTIONAL) Uncompensated Relationships - Abbvie; Array BioPharma; Eisai; Genmab; Janssen; Lilly; MSD; Novartis; PharmaMar; Roche; Sanofi
 
Miguel F. Sanmamed
Consulting or Advisory Role - Numab; Pieris Pharmaceuticals
Speakers' Bureau - Bristol-Myers Squibb; MSD
Research Funding - Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Roche
 
Maria E. Rodriguez-Ruiz
Honoraria - Bristol-Myers Squibb; Roche
Speakers' Bureau - Bristol-Myers Squibb; Roche
Research Funding - Bioncotech (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Roche
 
Petra Fettes
Employment - Catalym
Stock and Other Ownership Interests - Amgen
 
Kathrin Klar
Employment - Catalym
 
Manfred Ruediger
Employment - Catalym
Leadership - 4SC; Catalym
Stock and Other Ownership Interests - 4SC; Catalym
 
Christine Schuberth-Wagner
Employment - Catalym
Leadership - Catalym
Stock and Other Ownership Interests - Catalym
Honoraria - Lodo Therapeutics
Consulting or Advisory Role - Lodo Therapeutics
Patents, Royalties, Other Intellectual Property - MSD; University of Bonn
 
Markus Haake
Employment - Catalym
Stock and Other Ownership Interests - Catalym
Patents, Royalties, Other Intellectual Property - University of Wuerzburg
 
Joerg Wischhusen
Leadership - Catalym
Stock and Other Ownership Interests - Catalym
Consulting or Advisory Role - Catalym
Research Funding - Aeterna Zentaris (Inst); Catalym (Inst)
Patents, Royalties, Other Intellectual Property - Catalym (Inst)
 
Eugen Leo
Employment - Catalym; T-Knife
Leadership - Catalym; T-Knife
Stock and Other Ownership Interests - Catalym; T-Knife